Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Adult Hypopigmented Mycosis Fungoides Linked to Low Progression Risk
June 2026
Most adults with hypopigmented mycosis fungoides presented with early-stage disease and experienced low rates of progression in a large US cohort study.
Read more
19 Jun 2026
Adult Hypopigmented Mycosis Fungoides Linked to Low Progression Risk
Most adults with hypopigmented mycosis fungoides presented with early-stage disease and experienced low rates of progression in a large US cohort study.
17 Jun 2026
Skin Cancer Screening Programme Shows No Melanoma Mortality Benefit
A large study of Germany’s national skin cancer screening programme found no significant difference in melanoma death rates compared with neighbouring countries.
15 Jun 2026
Secukinumab Shows Sustained Long-Term Effectiveness and Safety
New 7-year real-world data show sustained efficacy and safety of secukinumab in psoriasis, with rising PASI responses over time.
12 Jun 2026
Experts Outperform AI in Real-World Skin Cancer Detection
Modern AI models can outperform junior clinicians in skin cancer diagnosis but remain less accurate than experienced dermatologists.
10 Jun 2026
Weight-Loss Interventions can Improve Psoriasis Symptoms
Weight-loss interventions improved the severity of psoriasis and quality of life in a 2026 systematic review and meta-analysis.
5 Jun 2026
Phototherapy Remains Effective and Safe in Elderly Psoriasis Patients
Phototherapy shows similar efficacy in elderly and younger psoriasis patients, with fewer side effects in older adults. Read more.
3 Jun 2026
Inherited Melanoma Risk Genes Linked to Wider Range of Cancers
Large genome study finds familial melanoma gene variants are more common than thought and linked to wider cancer risks across populations.
1 Jun 2026
Global Study Examines Educational Impact of Atopic Dermatitis
International study finds childhood-onset atopic dermatitis may limit education, career choices, and psychosocial wellbeing into adulthood.
Loading posts...
1
2
3
…
51
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View